

Twill's VP of Quality and Regulatory Affairs speaks on Reshaping the Future of Clinical Trials for Digital Therapeutics.
The therapeutic industry has relied on clinical trials as its tried and true method for evaluating efficacy for decades. However, in the new age of digital health, these trials are proving to be less efficient. How do we, as an industry, transform the model for digital interventions?
Listen to this recent DTx East 2021 panel discussion on Reshaping the Future of Clinical Trials for Digital Therapeutics with Kimberly Tableman, Castor’s Chief Clinical Development Officer, Athena Robinson, Woebot Health’s Chief Clinical Officer, and Mona Dean, Twill’s VP of Quality and Regulatory Affairs. They discuss:
Twill is available globally in 10 languages, supports more than 10 chronic conditions, and covers more than 20 million lives.
Request a demo@2022 Twill Inc.
All rights reserved.